Cargando…

Serum Selenium Level Predicts 10-Year Survival after Breast Cancer

In a recent prospective study, we reported an association between a low serum selenium level and five-year survival among breast cancer patients. We now have updated the cohort to include 10-year survival rates. A blood sample was obtained from 538 women diagnosed with first primary invasive breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szwiec, Marek, Marciniak, Wojciech, Derkacz, Róża, Huzarski, Tomasz, Gronwald, Jacek, Cybulski, Cezary, Dębniak, Tadeusz, Jakubowska, Anna, Lener, Marcin, Falco, Michał, Kładny, Józef, Baszuk, Piotr, Duszyński, Jerzy, Kotsopoulos, Joanne, Narod, Steven A., Lubiński, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998294/ https://www.ncbi.nlm.nih.gov/pubmed/33809461 http://dx.doi.org/10.3390/nu13030953

Ejemplares similares

Blood Copper Levels and the Occurrence of Colorectal Cancer in Poland
por: Baszuk, Piotr, et al.
Publicado: (2021)

Blood arsenic levels and the risk of familial breast cancer in Poland
por: Marciniak, Wojciech, et al.
Publicado: (2019)

Low Blood-As Levels and Selected Genotypes Appears to Be Promising Biomarkers for Occurrence of Colorectal Cancer in Women
por: Baszuk, Piotr, et al.
Publicado: (2021)

Serum Selenium Level and 10-Year Survival after Melanoma
por: Rogoża-Janiszewska, Emilia, et al.
Publicado: (2021)

Risk of Second Primary Thyroid Cancer in Women with Breast Cancer
por: Cieszyńska, Monika, et al.
Publicado: (2022)

Blood Arsenic Levels as a Marker of Breast Cancer Risk among BRCA1 Carriers
por: Marciniak, Wojciech, et al.
Publicado: (2021)

Serum selenium level and cancer risk: a nested case-control study
por: Narod, Steven A., et al.
Publicado: (2019)

Serum Essential Elements and Survival after Cancer Diagnosis
por: Lubiński, Jan, et al.
Publicado: (2023)

Genetic testing for hereditary breast cancer in Poland: 1998–2022
por: Gronwald, Jacek, et al.
Publicado: (2023)

Selenium as diagnostic marker of cancers
por: Jaworska-Bieniek, Katarzyna, et al.
Publicado: (2015)

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor
por: Ogrodniczak, Alicja, et al.
Publicado: (2022)

Serum Iron Level and 10-Year Survival after Melanoma
por: Rowińska, Karolina, et al.
Publicado: (2022)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

BARD1 is a Low/Moderate Breast Cancer Risk Gene: Evidence Based on an Association Study of the Central European p.Q564X Recurrent Mutation
por: Suszynska, Malwina, et al.
Publicado: (2019)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population
por: Białkowska, Katarzyna, et al.
Publicado: (2020)

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
por: Łukomska, Alicja, et al.
Publicado: (2021)

Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population
por: Rogoża-Janiszewska, Emilia, et al.
Publicado: (2020)

Genetic predisposition to male breast cancer in Poland
por: Szwiec, Marek, et al.
Publicado: (2021)

Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from Poland
por: Rogoża-Janiszewska, Emilia, et al.
Publicado: (2020)

Serum selenium levels and the risk of progression of laryngeal cancer
por: Lubiński, Jan, et al.
Publicado: (2018)

Selenium as a marker of cancer risk and of selection for control examinations in surveillance
por: Lener, Marcin, et al.
Publicado: (2015)

The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population
por: Gliniewicz, Katarzyna, et al.
Publicado: (2023)

Correction: Serum selenium levels and the risk of progression of laryngeal cancer
por: Lubiński, Jakub, et al.
Publicado: (2018)

Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population
por: Białkowska, Katarzyna, et al.
Publicado: (2018)

Inherited variants in XRCC2 and the risk of breast cancer
por: Kluźniak, Wojciech, et al.
Publicado: (2019)

Copper as diagnostic marker of cancers
por: Muszyńska, Magdalena, et al.
Publicado: (2015)

Magnesium as a diagnostic marker of cancer
por: Marciniak, Wojciech, et al.
Publicado: (2015)

Influence of the Levels of Arsenic, Cadmium, Mercury and Lead on Overall Survival in Lung Cancer
por: Pietrzak, Sandra, et al.
Publicado: (2021)

BRCA1 founder mutations compared to ovarian cancer in Belarus
por: Savanevich, Alena, et al.
Publicado: (2014)

Coverage of the Genetic Background of Breast Cancer in the Polish Population
por: Serrano-Fernández, Pablo, et al.
Publicado: (2006)

A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet
por: Huzarski, Tomasz, et al.
Publicado: (2006)

Zinc as diagnostic marker of cancers
por: Kaczmarek, Katarzyna, et al.
Publicado: (2015)

Iron as diagnostic marker of cancer
por: Sukiennicki, Grzegorz, et al.
Publicado: (2015)

Selenium and the risk of cancer of the lung and larynx. A case-control study from a region with low selenium
por: Jaworska, Katrzyna, et al.
Publicado: (2012)

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Iron and breast cancer risk
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer
por: Lener, Marcin R., et al.
Publicado: (2016)

Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet
por: Lubiński, J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_nel2snm7tnapn62ic5or7eclcp